Accessibility Menu
Merck KGaA logo

Merck KGaA

(OTC) MKGAF

Current Price$164.15
Market Cap$71.37BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2003)+496%
5 Year-11%
1 Year+24%
1 Month+4%

Merck KGaA Financials at a Glance

Market Cap

$71.37BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€20.97B

Net Income (TTM)

€2.54B

EPS (TTM)

$6.75

P/E Ratio

24.31

Dividend

$2.58

Beta (Volatility)

0.48 (Low)

Price

$164.15

Volume

115

Open

$164.20

Previous Close

$164.15

Daily Range

$157.58 - $166.23

52-Week Range

$116.68 - $175.56

Estimated Earnings Date

Aug 6, 2026

MKGAF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Merck KGaA

Industry

Pharmaceuticals

Employees

62,477

CEO

Belén Garijo López, MD

Headquarters

Darmstadt, HE 64293, DE

MKGAF Financials

Key Financial Metrics (TTM)

Gross Margin

58.53%

Operating Margin

19.41%

Net Income Margin

12.09%

Return on Equity

8.77%

Return on Capital

10.02%

Return on Assets

4.77%

Earnings Yield

4.11%

Dividend Yield

1.57%

Payout Ratio

11.76%

Stock Overview

Market Cap

$71.37BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

434.78M

Volume

115

Avg. Volume

695.581

Financials (TTM)

Gross Profit

€12.28B

Operating Income

€3.89B

EBITDA

€6.55B

Operating Cash Flow

€4.46B

Capital Expenditure

-€1.76B

Free Cash Flow

€2.70B

Cash & ST Invst.

€3.77B

Total Debt

€12.08B

Merck KGaA Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

€5.15B

-2.4%

Gross Profit

€3.08B

-2.2%

Gross Margin

59.70%

N/A

Market Cap

$71.37BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.21M

N/A

Employees

59,020

N/A

Net Income

€662.51M

-9.9%

EBITDA

€1.49B

-0.8%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

€3.77B

+133.0%

Total Debt

€12.08B

+28.4%

Accounts Receivable

€4.80B

+7.3%

Inventory

€4.80B

+6.4%

Long Term Debt

€10.84B

+43.9%

Short Term Debt

€1.24B

-28.4%

Return on Assets

4.77%

N/A

Return on Invested Capital

9.30%

N/A

Free Cash Flow

€366.39M

+1045.0%

Operating Cash Flow

€821.11M

+47.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IPSEYIpsen S.A.
$47.72-1.65%
WUXIFWuXi AppTec Co., Ltd.
$20.58-2.12%
HOCPYHOYA Corporation
$155.72+0.82%
SEMHFSiemens Healthineers AG
$39.15-4.50%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$16.95-0.01%
FRMIFermi
$6.59-0.10%
ONDSOndas
$7.26-0.05%
TAT&T
$21.13+0.02%

Questions About MKGAF

What is the current price of Merck KGaA?

Merck KGaA is trading at $164.15 per share.

What is the 52-week range for Merck KGaA?

Over the past 52 weeks, Merck KGaA has traded between $116.68 and $175.56.

How much debt does Merck KGaA have?

As of the most recent reporting period, Merck KGaA reported total debt of €13.87B.

How much cash does Merck KGaA have on hand?

Merck KGaA reported €3.16B in cash and cash equivalents in its most recent financial results.

What is Merck KGaA’s dividend yield?

Merck KGaA currently has a dividend yield of 1.57%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.